| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Johnson & Johnson (JNJ) has 23 insiders with recent SEC Form 4 filings, including 4 buys and 7 sells. JNJ is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.04M | $1.04B | - | |
| VP | 114.3K | $29.34M | - | |
| CEO | 79.6K | $20.44M | - | |
| VP | 46.2K | $11.87M | - | |
| VP | 46.1K | $11.82M | -23,054 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2019 | Hewson Marillyn A | Director | Buy | 3,000 | $139.68 | $419,040.00 | New | |
| Dec 14, 2018 | Perez William D | Director | Buy | 1,000 | $133.91 | $133,910.00 | +12.3% | |
| Dec 14, 2018 | Prince Charles | Director | Buy | 2,000 | $134.37 | $268,731.20 | +7.5% | |
| Dec 14, 2018 | Mulcahy Anne M | Director | Buy | 748 | $133.76 | $100,049.94 | +12.9% | |
| Dec 13, 2018 | Kapusta Ronald A | Controller, CAO | Sell | 3,643 | $147.31 | $536,637.58 | -21.1% | |
| Dec 4, 2018 | Fasolo Peter61 | Exec VP, Chief Hr Officer | Sale+OE | 166,695 | $146.41 | $24,405,240.86 | -51.6% | |
| Nov 23, 2018 | Sneed Michael E | EVP, Global Corp Aff &COO | Sale+OE | 30,943 | $142.46 | $4,407,985.07 | -43.7% | |
| Nov 16, 2018 | Gorsky Alex | Chairman, CEO | Sale+OE | 264,465 | $145.96 | $38,600,967.60 | -44.0% | |
| Nov 8, 2018 | Kapusta Ronald A | Controller, CAO | Sell | 8,441 | $145.15 | $1,225,200.18 | -32.8% | |
| Nov 7, 2018 | Duato Joaquin | Vice Chair, Exec Committee | Sale+OE | 40,000 | $144.36 | $5,774,480.00 | -30.0% |